This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/EYPT/capital-change-brief"
Use Arkolith's capital_change_brief for EYPT. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | SUVRETTA CAPITAL MANAGEMENT, LLC | $106.9M | 8.3M | ▲+6.0% Added · +469K sh | Q1 2026 | |
| 2 | Cormorant Asset Management, LP | $106.5M | 8.3M | —Held | Q1 2026 | |
| 3 | BlackRock, Inc. | $92.5M | 7.2M | ▲+5.7% Added · +389K sh | Q1 2026 | |
| 4 | FEDERATED HERMES, INC. | $73.1M | 5.7M | ▼−5.8% Reduced · −348K sh | Q1 2026 | |
| 5 | FRANKLIN RESOURCES INC | $65.1M | 5.0M | ▲+1.4% Added · +72K sh | Q1 2026 | |
| 6 | JANUS HENDERSON GROUP PLC | $46.4M | 3.6M | ▲+23% Added · +663K sh | Q1 2026 | |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | $45.9M | 3.6M | ▲New +3.6M sh | Q1 2026 | |
| 8 | ADAGE CAPITAL PARTNERS GP, L.L.C. | $42.5M | 3.3M | ▼−30% Reduced · −1.4M sh | Q1 2026 | |
| 9 | Paradigm Biocapital Advisors LP | $40.5M | 3.1M | ▼−15% Reduced · −549K sh | Q1 2026 | |
| 10 | Commodore Capital LP | $36.4M | 2.8M | ▲New +2.8M sh | Q1 2026 | |
| 11 | STATE STREET CORP | $27.0M | 2.1M | ▲+14% Added · +262K sh | Q1 2026 | |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | $25.6M | 2.0M | ▲+4.4% Added · +84K sh | Q1 2026 | |
| 13 | CITADEL ADVISORS LLC | $24.6M | 1.9M | ▲Added Added · +1.9M sh | Q1 2026 | |
| 14 | Aberdeen Group plc | $22.4M | 1.7M | ▲+8.2% Added · +132K sh | Q1 2026 | |
| 15 | BALYASNY ASSET MANAGEMENT L.P. | $18.5M | 1.4M | ▲+142% Added · +843K sh | Q1 2026 | |
| 16 | Parkman Healthcare Partners LLC | $17.5M | 1.4M | ▲+25% Added · +267K sh | Q1 2026 | |
| 17 | EVENTIDE ASSET MANAGEMENT, LLC | $16.1M | 1.2M | ▲New +1.2M sh | Q1 2026 | |
| 18 | MORGAN STANLEY | $14.1M | 1.1M | ▲+390% Added · +872K sh | Q1 2026 | |
| 19 | ORBIMED ADVISORS LLC | $13.8M | 1.1M | ▼−57% Reduced · −1.4M sh | Q1 2026 | |
| 20 | 5AM Venture Management, LLC | $13.5M | 1.1M | —Held | Q1 2026 | |
| 21 | HSBC HOLDINGS PLC | $10.7M | 833K | ▲New +833K sh | Q1 2026 | |
| 22 | STEMPOINT CAPITAL LP | $10.5M | 811K | ▲+129% Added · +457K sh | Q1 2026 | |
| 23 | Patient Square Capital LP | $10.2M | 795K | ▲+1.9% Added · +15K sh | Q1 2026 | |
| 24 | VANGUARD PORTFOLIO MANAGEMENT LLC | $10.2M | 794K | ▲New +794K sh | Q1 2026 | |
| 25 | Artia Global Partners LP | $9.9M | 767K | —Held | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Jul 10, 2026 | Duker Jay S. | President and CEO, Director | Option exercise (M) | 17K | $0 |
| Jul 10, 2026 | Duker Jay S. | President and CEO, Director | Tax withholding (F) | 8K | $119K |
| Jul 10, 2026 | Duker Jay S. | President and CEO, Director | Option exercise (M) | 17K | $0 |
| Jun 30, 2026 | Ribeiro Ramiro | Chief Medical Officer | Option exercise (M) | 2K | $20K |
| Jun 30, 2026 | Ribeiro Ramiro | Chief Medical Officer | Option exercise (M) | 2K | $20K |
| Jun 30, 2026 | Ribeiro Ramiro | Chief Medical Officer | Sell (S) | 2K | $37K |
| Jun 30, 2026 | Ribeiro Ramiro | Chief Medical Officer | Sell (S) | 2K | $37K |
| Jun 30, 2026 | Ribeiro Ramiro | Chief Medical Officer | Option exercise (M) | 2K | $0 |
| Jun 30, 2026 | Ribeiro Ramiro | Chief Medical Officer | Option exercise (M) | 2K | $0 |
| May 25, 2026 | Elston George | Chief Financial Officer | Option exercise (M) | 8K | $0 |
| May 25, 2026 | Elston George | Chief Financial Officer | Tax withholding (F) | 4K | $47K |
| May 25, 2026 | Elston George | Chief Financial Officer | Option exercise (M) | 8K | $0 |
| Company | Co-held by | Combined value |
|---|---|---|
| BOSTON SCIENTIFIC CORPBSX | 52 funds | $1.4B |
| ELI LILLY & COLLY | 51 funds | $5.9B |
| INTUITIVE SURGICAL INCISRG | 50 funds | $2.3B |
| UNITEDHEALTH GROUP INCUNH | 50 funds | $2.2B |
| THERMO FISHER SCIENTIFIC INCTMO | 49 funds | $2.0B |
| HOME DEPOT INCHD | 48 funds | $3.0B |
| MERCK & CO. INC.MRK | 48 funds | $2.7B |
| SERVICENOW INCNOW | 48 funds | $1.3B |
| DANAHER CORPDHR | 48 funds | $1.2B |
| NVIDIA CORPNVDA | 47 funds | $33.7B |
| ADVANCED MICRO DEVICESAMD | 47 funds | $3.2B |
| ABBOTT LABORATORIESABT | 47 funds | $1.4B |
Ranked by how many of EYPT's institutional holders also hold each name, a cross-fund conviction signal. Via the MCP server (ticker.co_held).
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for EYPT. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes. Every panel above is one call to the Arkolith API & MCP server.